Identification and Treatment of Tickborne Diseases

For information about AMA PRA Category 2 credit™, visit the American Medical Association education hub and view page 10 and 11 of this document.

 

Target Audience           

This activity is targeted towards primary care practitioners.

Statement of Need

In the United States, vector-borne diseases, including those transmitted by ticks, are occurring more frequently and represent a significant public health concern.  The CDC reported the number of disease cases in the US and its territories caused by mosquito, tick, and flea bites grew more than threefold from 2004 to 2016. Tickborne diseases can be very serious and sometimes fatal, providers need to be aware of common symptoms. Because of the inherent delay in obtaining laboratory confirmation, early implementation of evidence-based treatment based on the patient’s clinical presentation is extremely important. 

Objectives

At the conclusion of this offering, the participant will be able to:

• Discuss common diseases related to tick bites.
• Summarize the clinical symptoms of tickborne diseases.
• Discuss diagnostic testing to confirm a tickborne disease.
• Define evidence-based treatment for tick-related diseases.

 

Moderator

Mark J. McDonald, MD, CPE, FAAP Medical Director, Norton Children’s Hospital & Norton Children’s Medical Center Professor, Department of Pediatrics Division of Pediatric Critical Care University of Louisville School of Medicine

Speaker

Victoria Statler, M.D. M.Sc Pediatric Infectious Disease Specialist Associate Professor of Pediatrics Pediatric Infectious Diseases at the University of Louisville Attending Physician Pediatric Transplant Infectious Diseases Service at Norton Children’s Hospital Norton Children’s Hospital

 

Date of Original Release | August 2020

All information referenced in this podcast was correct at the time of initial publication.

Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

For information related to nursing credits, contact Sally Sturgeon DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or [email protected].”

 

Resources for Additional Study 

John, M.D., Teny and Taege, M.D., Alan; Appropriate laboratory testing in Lyme Disease; Cleveland Clinic Journal of Medicine, Volume 86, Number 11, November 2019, pages 751 - 759.

Tickborne Diseases of the United States: A Reference Manual for Healthcare Providers, Fifth Edition, 2018. U.S. Department of Health and Humana Services, Centers for Disease Control and Prevention.

https://www.cdc.gov/ticks/tickbornediseases/TickborneDiseases-P.pdf

 

Xiaojing Chen, et.al; Epidemiology of tick-borne encephalitis in China, 2007-2018; PLoS ONE 14(12): e0226712.;  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0226712  .

 

 

Podcast editing and production:  www.unmuteaudio.com

 

Podcast: Identification and Management of Sports Related Concussions Evaluation and Credit: https://www.surveymonkey.com/r/MedChat16

Target Audience

This activity is targeted toward primary care specialties.

Statement of Need

It is estimated that 1.6 to 3.8 million sports-related concussions occur annually, which represents 5-9% of all sports injuries. Additionally, it is recognized that sports-related concussions are under reported in that they are not always recognized due to the difficulty of diagnosis. Literature reports that there is lack of awareness of published guidelines for concussion diagnosis and management. Providers should be aware of and utilize the latest guidelines and recommendations for the identification and/or management of sports-related concussions.

Objectives

At the conclusion of this offering, the participant will be able to:

1. Define sports related concussion.
2. Describe the symptoms of a concussion; physical, cognitive and affective.
3. Identify sideline assessment tools for a sports related concussion.
4. Discuss the management and treatment of sports related concussions.

Moderator

Ryan Nazar, M.D.

Clinical Effectiveness Director, Quality Management Norton Medical Group

Speakers

Tad D. Seifert, M.D.

Neurology
Norton Sports Neurology

Moderator, Speaker and Planner Disclosures

The moderator and planners for this activity have no potential or actual conflicts of interest to disclose. The speaker, Tad Seifert, M.D. has the following relationships: Eli Lily Pharmaceuticals (advisory board and speaker’s bureau), Amgen Pharmaceuticals (consultant and speaker’s bureau) and Allergan Pharmaceuticals (speaker’s bureau)

 

Commercial Support

There was no commercial support for this activity.

Physician Credits
American Medical Association

Accreditation

Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation

Norton Healthcare designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Credits

Kentucky Board of Nursing (KBN) Approved Provider: Norton Healthcare, provider number 4-0002-12-20-208. The program has been approved by Norton Healthcare for 1.2 contact hours which expires 12/31/2020. KBN approval of a continuing education provider does not constitute endorsement of program content. Nursing participants must attest to the number of hours of attendance and complete the evaluation to receive contact hours.

For more information related to nursing credits, contact Sally Sturgeon DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or

[email protected].

Date of Original Release |July 2020
Course Termination Date | July 31, 2022
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

Resources for Additional Study

Evaluation and Management of Concussion in Young Athletes

https://www.ncbi.nlm.nih.gov/pubmed/30017603

Sports-Related Concussion: Acute Management and Chronic Postconcussive Issues

https://www.ncbi.nlm.nih.gov/pubmed/29157505

Summary of Evidence-Based Guideline Update: Evaluation and Management of Concussion in Sports: Report of the Guideline Development Subcommittee of the American Academy of Neurology https://www.ncbi.nlm.nih.gov/pubmed/23508730

Current Recommendations for the Diagnosis and Treatment of Concussion in Sport: A Comparison of Three New Guidelines
https://www.ncbi.nlm.nih.gov/pubmed/23879529

 

Podcast:  Colon Cancer: Updates in Screening Guidelines

For information about AMA PRA Category 2 credit™, visit the American Medical Association education hub and view page 10 and 11 of this document.

 

Target Audience           

This activity is targeted toward internal medicine, family medicine and primary care specialties that provide primary care to patients with seizures and/or epilepsy.

Statement of Need

Colorectal cancer (CRC) is one of the top cancer-related deaths in the US, yet it is has been documented that implementing the latest screening protocols can reduce the incidence and mortality of CRC. In that most colon tumors develop in stages, screening can detect early-stage precancerous polyps before they become cancerous. Therefore it is critical for physicians to understand the latest screening protocols and recommendations for CRC.

Objectives

At the conclusion of this offering, the participant will be able to:

• List the risk factors for colorectal cancer.
• Understand the stages of colorectal disease development.
• Discuss the latest screening guidelines for colorectal cancer.
• Describe the different colorectal screening / diagnostic tools and indications.

 

Moderator

Ryan Nazar, M.D. Clinical Effectiveness Director, Quality Management Norton Medical Group

 

Speakers

Ryan Jones, M.D. Colon and Rectal Surgery Norton Surgical Specialists

Michelle Julien, M.D. Colon and Rectal Surgery Norton Surgical Specialists

 

Date of Original Release |June 2020

All information referenced in this podcast was correct at the time of initial publication.

Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected] 

For more information related to nursing credits, contact Sally Sturgeon DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or [email protected].

 

Resources for Additional Study 

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. https://www.ncbi.nlm.nih.gov/pubmed/30875085

Chapkin, Robert, et. al. Diet and Gut Microbes Act Cooridnately to Enhance Programmed Cell Death and Reduce Colorectal Cancer Risk. Digestive Diseases and Sciences (2020) 65: 840 – 851.

Issa, Iyad, and Noureddine, Malak. Colorectal cancer screening: An updated review of the available options. World Journal of Gastroenterology; 2017 July 28: 23(28): 5086 – 5096.

Primary tumor location and survival in colorectal cancer: A retrospective cohort study. https://www.ncbi.nlm.nih.gov/pubmed/32368319

Stoffel, Elena, and Murphy Caitlin. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology, 2020 (158:341 – 353.)

Primary tumor location and survival in colorectal cancer: A retrospective cohort study. https://www.ncbi.nlm.nih.gov/pubmed/32368319

Xyu, M.D., Zhaomin, et. al. Treatments for Stage IV Colon Cancer and Overall Survival. Journal of Surgical Research, October 2019 (242) 47 – 56.

 

Podcast editing and production:  www.unmuteaudio.com

Treating Challenging Personalities in Primary Care

For information about AMA PRA Category 2 credit™, visit the American Medical Association education hub and view page 10 and 11 of this document.

Target Audience           

This activity is targeted towards all physician specialties.  

Statement of Need

In the United States, approximately 9% of adult patients have a personality disorder.  In the primary care setting approximately 18% of patients that are treated have some type of personality disorder.  Primary care practitioners do not consistently recognize or manage personality disorders when treating patients for medical related illnesses.

Clinicians should be aware of patient characteristics and symptoms that are related to personality disorders and effectively address and manage when providing primary care.

 

Objectives

At the conclusion of this offering, the participant will be able to:

• Discuss basic personality traits.
• Define different personality disorders.
• List the risk factors for personality disorders.
• Explain the distinct diagnostic criteria of personality disorders.
• Discuss effective management strategies and treatment of patients with personality disorders.

Moderator

Joseph M. Flynn, D.O, MPH, FACP Chief Administrative Officer Norton Medical Group Physician-in-Chief Norton Cancer Institute

Speaker

John J. Wernert, M.D., MHA, DLFAPA Executive Medical Director, Behavioral Health Services Norton Medical Group

 

Date of Original Release | April 2020

All information referenced in this podcast was correct at the time of initial publication.

Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

 

Resources for Additional Study 

The State Of Mental Health In America https://www.mhanational.org/issues/state-mental-health-america

CDC Mental Health Website https://www.cdc.gov/mentalhealth/index.htm

Dos and Don'ts in Treatments of Patients With Narcissistic Personality Disorder https://www.ncbi.nlm.nih.gov/pubmed/32186986

 

Podcast editing and production:  www.unmuteaudio.com

The Hidden Dangers of Vaping and the Pediatric Patient   For information about AMA PRA Category 2 credit™, visit the American Medical Association education hub and view page 10 and 11 of this document.   Target Audience               This activity is targeted towards all physician specialties.   Statement of Need Introduced in 2007, vaping has been promoted as a safe alternative to smoking. Research shows in 2017 vaping was the most common use of any tobacco-like product in adolescents,  with an estimated 1.3 million new adolescents using electronic cigarettes in 2018. In December of 2018, the US Surgeon General declared electronic cigarettes (EC) as an epidemic among youth. Evidence has linked vaping to an increase in acute lung injuries referred to as vaping-related acute lung injury (VpALI) and addiction in the adolescent/young adult population.   Objectives   At the conclusion of this offering, the participant will be able to:

• Define vaping-related acute lung injury (VpALI).
• Describe the contributing factors of vaping to acute lung injury.
• Discuss the symptoms, diagnostic guidelines and treatment protocols for VpALI.
• Implement an inclusive social history in determining patients utilizing electronic cigarettes / vaping and associated risks.

  Moderator Mark J. McDonald, MD, CPE, FAAP Medical Director, Norton Children’s Hospital & Norton Children’s Medical Center Professor, Department of Pediatrics Division of Pediatric Critical Care University of Louisville School of Medicine   Speaker Scott G. Bickel, M.D. Assistant professor Division of pediatric pulmonology Department of pediatrics University of Louisville School of Medicine     Date of Original Release | March 2020

All information referenced in this podcast was correct at the time of initial publication.

  Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]   Resources for Additional Study     Abeles, M.D., Michael, et.al., “Vaping-associated lung injury caused by inhalation of cannabis oil”, Pediatric Pulmonology, 2019; 1-3.   Al-Hamdani, Mohammed, et. al., “Vaping among youth and young adults: a “red alert” state”, Journal of Public Health Policy, October 2019.   Blagev, Denitza, P., Harris, Dixie, et. al., “Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study”, The Lancet, Vol 394, December 7, 2019, pages 2073 – 2083.   Bozier, Jack, et. al., “How harmless are E-cigarettes? Effects in the pulmonary system”, Current Opinion Pulmonary Medicine, 2020, 26:97-102.   Fonesca Fuentes, Xavier, et. al., “VpALI-Vaping-related Acute Lunch Injury: A New Killer Around the Block”, Mayo Clinic Proceedings, December 2019; 94)12): 2534-2545.   Gray, Naudia, Halstead, Mary, et. al., “Analysis of Toxic Materials in Liquid From Electronic Cigarettes”. International Journal of Environmental Research and Public Health, 2019, 16, 4450.    

Podcast editing and production:  www.unmuteaudio.com

DEA Provider Compliance and Safe Guards: Part 2

Evaluation and Credit: https://www.surveymonkey.com/r/MedChat11part2

Target Audience

This activity is targeted toward all physician specialties.

Statement of Need

Providers should be aware of the latest guidelines related to the prescribing of controlled substances as related to the administrative aspect of their practice to avoid any compliance issues.

Objectives

At the conclusion of this offering, the participant will be able to:

• Address common concerns for DEA compliance in practice.
• Identify red flags for a DEA investigation.

Moderator
Stephen Wright, M.D. Medical Director, Pediatrics Norton Medical Group

Speaker
Dennis Wichern
Managing Partner
Prescription Drug Consulting LLC Former Special Agent-in-Charge (SAC) Drug Enforcement Administration (DEA)

Speaker Disclosure

The speaker has no potential or actual conflicts of interest to disclose.

Moderator and Planner Disclosures

The moderator and planners for this activity have no potential or actual conflicts of interest to disclose.

 

Commercial Support

This activity has received financial support from Cardinal Health.

Physician Credits
American Medical Association

Accreditation

Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation
Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release | February 2020
Course Termination Date | February 28, 2022
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

Resources for Additional Study

How To Avoid Negative Press and Fines During the Opioid Crisis

https://www.prescriptiondrugconsulting.com/articles/how-to-avoid-negative-press-and-fines-during-the-opioid-crisis

U.S. Department of Justice Drug Enforcement Administration Diversion Control Division

https://www.deadiversion.usdoj.gov/index.html

Don't Be Scammed By A Drug Abuser

https://www.deadiversion.usdoj.gov/pubs/brochures/drugabuser.htm

Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
https://www.ncbi.nlm.nih.gov/pubmed/30045589

Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines

https://www.ncbi.nlm.nih.gov/pubmed/28226332

DEA Provider Compliance and Safe Guards: Part One

Evaluation and Credit: https://www.surveymonkey.com/r/MedChat11part1

Target Audience

This activity is targeted toward all physician specialties.

Statement of Need

Providers should be aware of the latest guidelines related to the prescribing of controlled substances as related to the administrative aspect of their practice to avoid any compliance issues.

Objectives

At the conclusion of this offering, the participant will be able to:

• Define the role of the Drug Enforcement Agency (DEA).
• Discuss key aspects of compliance relative to the practice setting in the prescribing of controlled substances.
• Recognize important and recurring opioid risk areas.
• List practical strategies and tips to reduce opioid risks.

Moderator
Stephen Wright, M.D. Medical Director, Pediatrics Norton Medical Group

Speaker
Dennis Wichern
Managing Partner
Prescription Drug Consulting LLC Former Special Agent-in-Charge (SAC) Drug Enforcement Administration (DEA)

Speaker Disclosure

The speaker has no potential or actual conflicts of interest to disclose.

Moderator and Planner Disclosures

The moderator and planners for this activity have no potential or actual conflicts of interest to disclose.

 

Commercial Support

This activity has received financial support from Cardinal Health.

Physician Credits
American Medical Association

Accreditation

Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation
Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HB1 / Prescribing Controlled Substances
The Kentucky Board of Medical Licensure has approved the podcast DEA Provider Compliance and Safe Guards:

Part One for .50 HB1 credit hours. ID# 0120-H.50-NHC1d.

Date of Original Release | February 2020
Course Termination Date | February 28, 2022
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

Resources for Additional Study

How To Avoid Negative Press and Fines During the Opioid Crisis

https://www.prescriptiondrugconsulting.com/articles/how-to-avoid-negative-press-and-fines-during-the-opioid-crisis

U.S. Department of Justice Drug Enforcement Administration Diversion Control Division

https://www.deadiversion.usdoj.gov/index.html

Don't Be Scammed By A Drug Abuser

https://www.deadiversion.usdoj.gov/pubs/brochures/drugabuser.htm

Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
https://www.ncbi.nlm.nih.gov/pubmed/30045589

Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines

https://www.ncbi.nlm.nih.gov/pubmed/28226332

Vaccine Hesitancy: Scope and Solutions 

Evaluation and Credit: https://www.surveymonkey.com/r/MedChat10

 

Target Audience            

This activity is targeted towards internal medicine, family medicine, pediatrics, and urgent care.  

Statement of Need

In January 2019, the World Health Organization included ‘vaccine hesitancy’ as one of the top 10 threats to global health.  Providers should be aware of current philosophies towards vaccine hesitancy, be current on the AAP vaccination schedule, and be knowledgeable in techniques to talk with families that are vaccine hesitant.

Objectives

At the conclusion of this offering, the participant will be able to:

• Define vaccine hesitancy.
• Describe factors that influence a family's tendency to be vaccine hesitant.
• Discuss effective strategies to address vaccine hesitancy with parents.
• Understand the scientific data about the safety and efficacy of vaccines and risks of non-vaccination.

Moderator

Mark J. McDonald, MD, CPE, FAAP Medical Director, Norton Children’s Hospital & Norton Children’s Medical Center Professor, Department of Pediatrics Division of Pediatric Critical Care University of Louisville School of Medicine

Speaker Gary S. Marshall, MD Professor of Pediatrics Chief, Division of Pediatric Infectious Diseases University of Louisville School of Medicine

Speaker Disclosure

The speaker has the following conflicts of interest to disclose:  Advisory Board, Consultant, Grant Recipient, Honoraria and Research – GSK, Merck, Pfizer, Sanofi, and Seqirus.

 

Moderator and Planner Disclosures 

The moderator and planners for this activity have no potential or actual conflicts of interest to disclose.

Commercial Support 

This activity has not received commercial support.

 

Physician Credits   American Medical Association

 

Accreditation

Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

 

Designation

Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

Date of Original Release | December 2019 Course Termination Date | January, 2022; Updated to December 2025 Content review: This podcast was reviewed Dcember 2021 by Gary S. Marshall, M.D. It was determined that the information is still relevant and appropriate.

Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

 

Resources for Additional Study  

Vaccine Hesitancy, History, and Human Nature: The 2018 Stanley A. Plotkin Lecture https://academic.oup.com/jpids/article-abstract/8/1/1/5099088?redirectedFrom=fulltext   The Vaccine Handbook: A Practical Guide for Clinicians, 8E "The Purple Book" https://pcibooks.com/books/view/49   Vaccine Hesitancy: Where We Are and Where We Are Going https://www.ncbi.nlm.nih.gov/pubmed/28774498   Vaccine Hesitancy in Pediatric Primary Care Practices https://www.ncbi.nlm.nih.gov/pubmed/29947574   Vaccine Hesitancy: Causes, Consequences, and a Call to Action https://www.ncbi.nlm.nih.gov/pubmed/26337116

 

A recent study concluded that 12 percent of Americans suffer from migraine headaches and migraines/headaches is a top diagnosis for physician visits.  Providers should be current on recognizing the symptoms of migraines as well as how to treat migraines or when to refer to a neurologist.

Addressing Provider Wellness and Resilience 

For information about AMA PRA Category 2 credit™, visit the American Medical Association education hub and view page 10 and 11 of this document.

Target Audience 

This activity is targeted toward internal medicine, family medicine and all specialties. 

Statement of Need 

A 2015 Mayo Clinic study found that more than half of U.S. doctors experience at least one symptom of burnout, and dissatisfaction has significantly worsened in recent years. Physician stress and burnout can impact the quality of patient care as well as a physicians' own health and well-being. It is important for physicians to recognize the symptoms of burnout and to identify strategies/habits to promote resilience and work-life balance. 

Objectives 

At the conclusion of this offering, the participant will be able to: 

• Discuss the contributing factors and symptoms of burnout. 
• Describe strategies / resources to address clinician burnout and resilience. 

Moderator 

James Jennings, M.D. 

Executive Medical Director, Adult Primary Care Director, Provider Wellbeing Norton Healthcare 

Speaker 

Paul F. DeChant, M.D., MBA, FAAFP 

Deputy Chief Health Officer IBM Watson Health 

 

Date of Original Release | November 2019 

All information referenced in this podcast was correct at the time of initial publication.

Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected] 

Resources for Additional Study 

Paul DeChant, Diane W. Shannon, Preventing Physician Burnout: Curing the Chaos and Returning Joy to the Practice of Medicine, CreateSpace Indepdent Publishing Platform, 2016, http://www.pauldechantmd.com/preventing-physician-burnout/ 

Bob Chapman and Raj Sisodia, Everybody Matters: The Extraordinary Power of Caring for Your People Like Family, Penguin Random House LLC, 2015, https://www.everybodymattersbook.com/ 

Brenda K. Wiederhold, et. al., Intervention for Physician Burnout: A Systematic Review, De Gruyter, Open Med. 2018; 13: 253-263 

Hilary McClaffety, M.D., FAAO, et. al. Physician Health and Wellness, American Academy of Pediatrics, Volume 134, Number 4, October 2014, pp. 830-835 

Mark Linzer, M.D., et. al., 10 Bold Steps to Prevent Burnout in General Internal Medicine, J Gen Intern Med 29(1):18–20, DOI: 10.1007/s11606-013-2597-8 

C. P. West, et. al., Physician Burnout: Contributors, Consequences and Solutions, Journal of Internal Medicine, 

Journal of Internal Medicine, 2018, 283; 516–529 

 

Podcast editing and production:  www.unmuteaudio.com